Dick’s Sporting Goods Closes $2.4 Billion Foot Locker Deal
Read the latest as Dick’s Sporting Goods closes a massive $2.4 billion deal with Foot Locker, a move that coincides with the departure of Mary Dillon. Learn more.
Read the latest as Dick’s Sporting Goods closes a massive $2.4 billion deal with Foot Locker, a move that coincides with the departure of Mary Dillon. Learn more.
Explore the curious SPAC deal taking nuclear startup Deep Fission public. We analyze the risks, rewards, and what this move means for the future of the energy sector.
Get the latest biotech fundraising news. Our tracker covers the most recent funding rounds for innovative companies like nrg tx, Epigenic, and other key players.
BioNTech and BMS reveal promising first global data for their new pd-l1xvegf drug, a novel bispecific antibody targeting Small Cell Lung Cancer (SCLC) patients.
Junshi Biosciences reports a major phase 3 win for its new il-17 drug targeting psoriasis, signaling a significant advancement and a planned push into the China market.
BioNTech and BMS reveal promising first-in-human global data for their novel PD-L1xVEGF bispecific antibody, showing potential in treating advanced solid tumors.
Atom’s new gout drug shows promising Phase 3 trial results, suggesting it could be a superior treatment option and effectively challenge current market leaders.
A top housing developer warns that the US is already in a housing emergency. Learn about the key factors deepening the crisis and what it means for the market.
A major housing developer warns America is already in an emergency as the housing crisis deepens. Learn why the affordability and supply issues are getting worse.
The OnlyFans boom on college campuses is sparking concern as more students turn to the platform for fast cash. We explore the risks and reasons behind this trend.